VEC’s MOSAIC and PREVENT-COVID studies

News

Posted on

As the BC government is encouraging everyone to make a final push to get as many people vaccinated as possible, it is also a great time to help out with COVID-19 vaccine research here in BC.

There are multiple research studies going on at the Vaccine Evaluation Center at BC Children’s Hospital — including the MOSAIC Study and the PREVENT-COVID Study — looking into the long-term impact on immune responses from COVID-19 vaccination and the effectiveness of mixing and matching different COVID-19 vaccines. You can participate from anywhere in BC.

VEC’s MOSAIC Study

The MOSAIC Study is looking for healthy individuals 18 years of age and older who have received their first dose of an authorized COVID-19 vaccine but have not received their second dose OR who have not received a COVID-19 vaccine.

Find out more:

MOSAIC


VEC’s PREVENT-COVID Study

The PREVENT-COVID Study is looking for adults 50 years of age and older before they have received a COVID-19 vaccine OR after they have received one or two doses of Moderna or AstraZeneca COVID-19 vaccine.

Find out more:

PREVENT-COVID
Kristen Hovet
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • Dads with kid in the pool
    News

    Research supports BC families in building healthy habits to prevent childhood obesity

    Unhealthy eating patterns, low physical activity, and a lot of sedentary or screen-related habits are linked to childhood obesity risk, which can lead to elevated blood pressure, sleep problems, orthopedic issues, and mental health challenges. Obesity-prevention resources that only focus on providing information often fall short because many families already know the basics. The biggest…

    Read more
  • News

    First-in-world BC patient successfully treated for rare immune disease

    A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”

    Read more
  • News

    Prescribing ice cream and countering misinformation: Q&A with Dr. Alastair McAlpine

    Born and raised in Johannesburg, Dr. Alastair McAlpine, a researcher with the Vaccine Evaluation Center (VEC) at BC Children’s Hospital Research Institute (BCCHR), is passionate about pediatric palliative care and infectious diseases. He received his medical training in South Africa, but limited vacancies to pursue a specialization in his desired field brought him to Vancouver. After meeting a…

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now